Envoy Medical, Inc. financial data

Symbol
COCH, COCHW on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
4875 White Bear Parkway, White Bear Lake, MN
Fiscal year end
December 31
Former names
Anzu Special Acquisition Corp I (to 9/29/2023)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 86.8 % +29%
Quick Ratio 19.8 %
Debt-to-equity -180 % -130%
Return On Equity 210 % +78.5%
Return On Assets -261 % -105%
Operating Margin -7.72K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.2M shares
Common Stock, Shares, Outstanding 19.5M shares
Entity Public Float 44.2M USD -89.4%
Weighted Average Number of Shares Outstanding, Basic 19.6M shares +92.1%
Weighted Average Number of Shares Outstanding, Diluted 19.6M shares +74.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 278K USD -30%
Research and Development Expense 10.7M USD +49%
Selling and Marketing Expense 1.73M USD -1.25%
General and Administrative Expense 2.51M USD +64.8%
Costs and Expenses 21.7M USD +45.2%
Operating Income (Loss) -21.5M USD -32.9%
Nonoperating Income (Expense) 318K USD -120%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 5.62M USD -132%
Income Tax Expense (Benefit) 2.36M USD +11.9%
Net Income (Loss) Attributable to Parent -21.1M USD +42.3%
Earnings Per Share, Basic -0.85 USD/shares -385%
Earnings Per Share, Diluted -0.85 USD/shares -385%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.22M USD +2205%
Accounts Receivable, after Allowance for Credit Loss, Current 197K USD +80.7%
Inventory, Net 1.64M USD +17.5%
Assets, Current 7.14M USD -64.9%
Property, Plant and Equipment, Net 1.2M USD +217%
Assets 9.4M USD -55.7%
Accounts Payable, Current 1.76M USD -48%
Accrued Liabilities, Current 6.85M USD +69.2%
Liabilities, Current 9.07M USD -28.5%
Other Liabilities, Noncurrent 127K USD
Liabilities 27.9M USD +70%
Accumulated Other Comprehensive Income (Loss), Net of Tax -121K USD -4.31%
Retained Earnings (Accumulated Deficit) -278M USD -10.6%
Stockholders' Equity Attributable to Parent -18.5M USD -487%
Liabilities and Equity 9.4M USD -55.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.85M USD -94.2%
Net Cash Provided by (Used in) Financing Activities 6.68M USD +67.1%
Net Cash Provided by (Used in) Investing Activities -109K USD -84.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 727K USD -21.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.42M USD -73.7%
Deferred Tax Assets, Valuation Allowance 5.78M USD +796%
Deferred Tax Assets, Gross 50.2M USD +13.1%
Operating Lease, Liability 1.25M USD +113%
Depreciation 34K USD +25.9%
Payments to Acquire Property, Plant, and Equipment 59K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.2M USD -482%
Lessee, Operating Lease, Liability, to be Paid 1.27M USD +113%
Lessee, Operating Lease, Liability, to be Paid, Year Two 223K USD +44.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 229K USD +41.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20K USD +122%
Lessee, Operating Lease, Liability, to be Paid, Year Three 230K USD +48.4%
Deferred Tax Assets, Operating Loss Carryforwards 41.2M USD +2.13%
Preferred Stock, Shares Issued 100M shares
Preferred Stock, Shares Authorized 100M shares
Unrecognized Tax Benefits 516K USD -5.32%
Lessee, Operating Lease, Liability, to be Paid, Year Four 195K USD +97%
Additional Paid in Capital 259M USD +1.25%
Preferred Stock, Shares Outstanding 4.5M shares
Deferred Tax Assets, Net of Valuation Allowance 50.2M USD +13.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares -100%